SNGX

Conviction 35HealthcareScan · Mon, Aug 10, 2026

Gravestone doji

SNGX$0.3830-2.32%

ResistanceSupportVol 14

Vol MA14 238.38K

May 11May 28Jun 16Jul 6Jul 23Aug 10

SOLIGENIX, INC.Pharmaceutical Preparationswww.soligenix.com ↗

Price0.3830

Change-2.32%

Gap-2.32%

Rel volume0.12×

Avg volume286.74K

Avg $ vol105.48K

SMA 200.3705

SMA 500.4183

SMA 2000.9931

Price vs 50-8.44%

Price vs 200-61.43%

MA stackbearish

50/200 cross—

Supertrenddown · 0.4285

RSI (14)49

MACD hist0.01

MACD cross—

Stoch %K / %D69 / 74

ADX (14)14

+DI / −DI20 / 16

RSI divergence—

MACD divergence—

ATR %+5.97%

ADR %5.20%

52w high4.96

52w low0.2801

From 52w high-92.28%

Above 52w low+36.74%

New 52w highNo

SqueezeOn · 28d

Bollinger width9.98%

%B0.84

Donchian pos71.89%

Donchian high0.3977

Donchian low0.3454

AVWAP (52w high)1.90

vs AVWAP high-79.82%

AVWAP (52w low)0.7645

vs AVWAP low-49.90%

OBV trendFlat

Chaikin MF (20)-0.02

Today vs 20d0.12×

Avg vol (14d)238.38K

Avg vol (20d)286.74K

Avg $ vol (20d)105.48K

Market cap8.34M

RS 3m (vs SPY)+21.53%

RS 6m (vs SPY)-76.41%

RS line new highNo

Trend template2/8

Technical rank20.1

1 week+1.46%

1 month+6.42%

3 months+30.72%

6 months-66.11%

1 year-88.36%

YTD-73.03%

P/E-0.75

P/B1.25

P/S69.83

P/FCF-0.81

EPS-2.14

Div yield—

ROE-166.73%

ROA-105.53%

Debt/Eq0.00

Current2.77

EV/EBITDA1.23

Gross margin81.52%

Net margin—

Rev growth0.00%

EPS growth-34.04%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-14.54M

Revenue2.34K

Net income-1.99M

Gross profit20K

Free cash flow-10.27M

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out14.82M

Employees14

ListedTue, Apr 5, 1994

Free float9.77M

Float %96.9%

Short interest483.44K

Days to cover1.1d

Short volume26.9%

Squeeze score15 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.12 vs −$0.22

Last surprise+45.5% beat

Setup gradeD

Conviction35 / 100

Pattern quality—

Tech rank20.1 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmGravestone doji

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SNGX

All disclosures →

No recent disclosed trades by Congress in SNGX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SNGX

No recent insider (Form 4) filings in SNGX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in SNGX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.